372 related articles for article (PubMed ID: 11345525)
1. A possible role for the WNT-1 pathway in oral carcinogenesis.
Lo Muzio L
Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
[TBL] [Abstract][Full Text] [Related]
2. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
3. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling.
Akiyama T
Cytokine Growth Factor Rev; 2000 Dec; 11(4):273-82. PubMed ID: 10959075
[TBL] [Abstract][Full Text] [Related]
5. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression.
Gradl D; Kühl M; Wedlich D
Mol Cell Biol; 1999 Aug; 19(8):5576-87. PubMed ID: 10409747
[TBL] [Abstract][Full Text] [Related]
6. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
7. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
8. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
10. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
11. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
13. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
14. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types.
Giarré M; Semënov MV; Brown AM
Ann N Y Acad Sci; 1998 Oct; 857():43-55. PubMed ID: 9917831
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
[TBL] [Abstract][Full Text] [Related]
17. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
18. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
19. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
